10 results for "Ferras Alashkar"
Showing 1–10 · 1.17 seconds · RSS
-
Journal Article
Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report
ABSTRACT Introduction Aplastic anemia (AA) is a rare bone marrow failure syndrome with pancytopenia, mainly due to immune‐mediated stem cell destruction. First‐line therapy for acquired severe AA ≥ 50 years/non‐severe AA (NSAA) requiring treatment is immunosuppressive therapy with horse…
-
Journal Article Full text
No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab
Introduction: Ravulizumab (ALXN1210) is a long-lasting recycling IgG monoclonal antibody with an increased affinity for the neonatal Fc receptor (FcRn). The FcRn is essential for regulating IgG homeostasis. Saturation of the FcRn pathway is seen under high IgG doses as they compete with endogenous…
Also available at: DOAJ
-
Journal Article
Cytopenia first – hepatitis second: an unusual sequence in aplastic anemia
Key Clinical Message To the best of our knowledge, this is the first report of aplastic anemia (AA) preceding autoantibody‐negative autoimmune hepatitis (AIH) with successful treatment of both conditions with the same immunosuppressive regimen, resulting in hematopoietic reconstitution and…
-
Journal Article
Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis
IntroductionThe marketing authorization for crizanlizumab (Adakveo®), indicated for the prevention of recurrent vaso-occlusive crises (VOCs) in sickle cell patients (pts) aged ≥16, was revoked by the European Medicines Agency (EMA) as the STAND study did not demonstrate a significant difference…
-
Journal Article
Safety and efficacy of voxelotor in adult patients with sickle cell disease
Abstract: On 25 September 2024, Pfizer announced the voluntary withdrawal of voxelotor because of an imbalance in vaso-occlusive crises (VOCs) and fatal events. Medical records of 31 patients with sickle cell disease (SCD) (October 2021-September 2024; median age, 33 years [range 21-55; homozygous…
-
Journal Article
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation
Pregnancies in paroxysmal nocturnal hemoglobinuria (PNH) are associated with increased morbidity and mortality. Retrospective studies suggest that outcome has improved with the advent of the complement inhibitor eculizumab. To substantiate this assumption we analyzed the data from patients treated…
-
Journal Article
Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study
Background: Beta-thalassemias (BTs) are characterized by deficient or absent synthesis of the beta-globin subunit, leading to anemia. Patient characteristics and treatment patterns in these patients may vary. Objective: This retrospective study evaluated demographics, clinical characteristics, and…
-
Journal Article
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives
Abstract This monocentric study conducted at the Pediatric and Adult Hemoglobinopathy Outpatient Units of the University Hospital of Essen summarizes the results of hemoglobinopathies diagnosed between August 2018 and September 2021, prior to the introduction of a general newborn screening (NBS)…